Skip to Main Content

More than one-third of U.S. adults believe that prescription drug prices have increased a lot since 2017, the first year of the Trump administration, and only 7% think prices have dropped at all, a new poll finds. Consequently, 65% of Americans say the administration has not made very much progress or no progress at all in limiting the rising cost of medicines.

The vast majority of Democrats and independents — 81% and 70%, respectively — believed that drug prices rose a little or a lot, while only 47% of Republicans shared that view. However, less than 10% among all three groups believed there was a decline in drug prices in the last three years, according to the poll from Gallup and West Health, a research and policy organization.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • One third of adults does not constitute a “majority” of adult Americans. Your headline is extremely misleading. Please be more open and truthful in the future. Thank you. This is the FIRST time I have commented on this matter!

    • Hi Mr. Northrop,

      Thanks for your note. The poll results state that:

      “Dovetailing with these results are perceptions of Trump’s progress in controlling rising drug costs, with 31% of Americans saying the Trump administration has made “a great deal” or “a fair amount” of progress, compared with 65% who report “not very much” progress or “none at all.”

      That 65% does constitute a majority of Americans surveyed.

      The 35% figure refers to Americans who believe drug prices rose a lot. Another 31% said drug prices rose a little.

      Hope this helps,
      ed at pharmalot

  • Yes, Most Americans are right ! That’s because Trump decided to NOT go after the PBM’s ! I guess that 2020 re election donation was more important than lowering drug prices !!!
    The only way drug prices will go down is to stop the PBM’s from fleecing this
    country !

  • Sigh. We should make policy based on facts, not on false beliefs.

    As Ed and others have reported, both list and net drug prices have been declining, not rising (and certainly not “skyrocketing”:

    Of course, these declines may or may not have been reflected in patients’ out-of-pocket costs. And to be clear, I’m not suggesting that the Trump administration can take credit for declining drug prices.

    Everyone is entitled to their own opinions, but not their own facts.

Comments are closed.